Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo
Completed · Phase 4 · Has a placebo group
Conditions studied: Hypercholesterolemia
In brief
The main purpose of this study is to evaluate the effect on mental state (known as "neurocognitive function") with use of Praluent.
Key facts
- Study ID
- NCT02957682
- Run by
- Regeneron Pharmaceuticals
- People needed
- 2176
- Starts
- 2016-11-02
- Expected to finish
- 2020-03-05
- Last updated by the study team
- 2021-05-07
Who can join
Age: 40 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Regeneron Study Site — Birmingham, Alabama, United States
- Regeneron Study Site — Mobile, Alabama, United States
- Regeneron Study Site — Beverly Hills, California, United States
- Regeneron Study Site — Los Gatos, California, United States
- Regeneron Study Site — North Hollywood, California, United States
- Regeneron Study Site — Port Hueneme, California, United States
- Regeneron Study Site — Westminster, California, United States
- Regeneron Study Site 1 — Aurora, Colorado, United States
- Regeneron Study Site 2 — Aurora, Colorado, United States
- Regeneron Study Site — Colorado Springs, Colorado, United States
- Regeneron Study Site — Lake Worth, Florida, United States
- Regeneron Study Site — Lake Worth, Florida, United States
- Regeneron Study Site — Miami Springs, Florida, United States
- Regeneron Study Site — Covington, Georgia, United States
- Regeneron Study Site — Champaign, Illinois, United States
- Regeneron Study Site — Chicago, Illinois, United States
- Regeneron Study Site — Chicago, Illinois, United States
- Regeneron Study Site — Rock Island, Illinois, United States
- Regeneron Study Site — Evansville, Indiana, United States
- Regeneron Study Site — Indianapolis, Indiana, United States
- Regeneron Study Site — Ames, Iowa, United States
- Regeneron Study Site — Iowa City, Iowa, United States
- Regeneron Study Site — Waterloo, Iowa, United States
- Regeneron Study Site — Hutchinson, Kansas, United States
- Regeneron Study Site — Auburn, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.